Direct-to-consumer laboratory testing (DTCT): challenges and implications for specialists in laboratory medicine

Area of Science:

• Clinical Diagnostics
• Healthcare Policy

Background:

• In vitro diagnostics (IVD) are crucial for medical diagnosis, with safety ensured by qualified personnel, process controls, and regulations.
• Direct-to-consumer laboratory testing (DTCT) allows individuals to order and perform tests, often with self-collected samples.
• Current DTCT models may lack sufficient regulatory oversight, creating potential risks for consumers.

Purpose of the Study:

• To highlight the potential risks associated with direct-to-consumer laboratory testing (DTCT).
• To emphasize the role of laboratory medicine specialists in educating the public about DTCT.
• To advocate for caution among specialists when new DTCTs emerge.

Main Methods:

• Review of current regulatory frameworks for IVD and DTCT.
• Analysis of potential risks and benefits of DTCT for laypersons.
• Discussion of the ethical obligations of laboratory medicine specialists.

Main Results:

• DTCT may bypass established safety and quality controls inherent in traditional IVD testing.
• Inadequate oversight of DTCT can lead to misinterpretation of results and potentially harmful healthcare decisions by consumers.
• Laboratory professionals have a critical role in informing patients about the limitations and risks of DTCT.

Conclusions:

• Healthcare professionals must exercise caution regarding the introduction and use of DTCT.
• There is a need for enhanced oversight and clear guidelines for DTCT to ensure patient safety.
• Laboratory medicine specialists should proactively educate patients and the public about the safe and appropriate use of diagnostic testing.